In this column, Reid D’Amico shares background on an investigational CF therapy called SPX-101, developed by Spyryx Biosciences, which has shown promise in early animal studies. Click here to read more from Reid.
Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.